Title: |
Fibroblast growth factor 21 is associated with increased serum total antioxidant capacity and oxidized lipoproteins in humans with different stages of chronic kidney disease. |
Authors: |
Gómez-Sámano, Miguel Ángel, Vargas-Abonce, Valerie Paola, Martínez-Sánchez, Froylan David, Palacios-Báez, Lucía, Vera-Zertuche, Juan Mauricio, Navarro-Flores, María Fernanda, Morales-García, Mariana Guadalupe, Fonseca-Correa, Jorge Ignacio, Zuarth-Vázquez, Julia María, Vega-Vega, Olynka, Correa-Rotter, Ricardo, Rincón-Pedrero, Rodolfo, Morales-Buenrostro, Luis E., Alberú-Gómez, Josefina, Ramírez-González, Julia Berenice, Pacheco-Domínguez, Reyna Lizette, López-Cervantes, Malaquías, Mendoza-de-la-Garza, María de los Ángeles, Baeza-Arias, Yolanda Victoria, Espinosa-Cuevas, Ángeles |
Source: |
Therapeutic Advances in Endocrinology & Metabolism; 3/29/2021, p1-13, 13p |
Database: |
Complementary Index |